RankingsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Cash from operations

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥91.7B
P/E ratio
29.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025-5,486-158.91%
Mar 31, 20249,312-269.31%
Mar 31, 2023-5,500-159.21%
Mar 31, 20229,289-10.17%
Mar 31, 202110,341+109.88%
Mar 31, 20204,927+26.17%
Mar 31, 20193,905+24.64%
Mar 31, 20183,133+18.17%
Mar 31, 20172,651+20.42%
Mar 31, 20162,202+341.19%
Mar 31, 2015499

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)